| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $144.8M | -21.6% | -0.0% |
| Cost of Revenue | $39.9M | -39.3% | -4.8% |
| SG&A Expense | $81.8M | -18.9% | +181.0% |
| Operating Income | -$233.5M | -100.6% | -899.3% |
| Pre-tax Income | -$254.1M | +24.8% | -2187.8% |
| Income Tax | -$6.3M | +96.6% | -224.2% |
| Net Income | -$247.8M | -59.5% | -1435.1% |
| EPS (Basic) | -$0.74 | -42.3% | -957.1% |
| EPS (Diluted) | -$0.74 | -42.3% | -957.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.21B | -32.1% | — |
| Accounts Receivable | $69.1M | +619.2% | — |
| Current Assets | $2.42B | -28.3% | — |
| Total Assets | $7.26B | +3.4% | — |
| Current Liabilities | $651.4M | -4.5% | — |
| Total Liabilities | $4.60B | +1.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $289.3M | — | — |
| Capital Expenditures | $1.67B | — | — |
| Investing Cash Flow | -$2.61B | — | — |
| Financing Cash Flow | $3.97B | — | — |
| Free Cash Flow | -$1.38B | — | — |
| Stockholders' Equity | $2.66B | +6.1% | +98.2% |